Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
American Journal of Public Health|May 4, 1999
Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996H R Yusuf, R W Rochat, W S Baughman, et al.
The Journal of Infectious Diseases|November 14, 1997
Molecular epidemiology of sporadic (endemic) serogroup C meningococcal diseaseN J Raymond, M Reeves, G Ajello, et al.
Infection and Immunity|March 20, 2001
Transcriptional regulation of divergent capsule biosynthesis and transport operon promoters in serogroup B Neisseria meningitidisY L Tzeng, J S Swartley, Y K Miller, et al.
The Journal of Infectious Diseases|February 1, 1996
Invasive group B streptococcal disease: the emergence of serotype VH M Blumberg, D S Stephens, M Modansky, et al.
Archives of Internal Medicine|September 22, 2000
Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patientsR F Breiman, D W Keller, M A Phelan, et al.
The Pediatric Infectious Disease Journal|July 1, 1993
Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccinesJ C Mohle-Boetani, G Ajello, E Breneman, et al.
Journal of Clinical Microbiology|April 1, 1990
Purification and characterization of a pilin specific for Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius (H. aegyptius) strainsR S Weyant, W F Bibb, D S Stephens, et al.
The American Journal of Medicine|February 1, 1985
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditisM P Weinstein, C W Stratton, A Ackley, et al.
The Journal of Infectious Diseases|November 24, 1999
The changing epidemiology of meningococcal disease in the United States, 1992-1996N E Rosenstein, B A Perkins, D S Stephens, et al.
The Journal of Infectious Diseases|January 7, 1999
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance GroupR A Hajjeh, L A Conn, D S Stephens, et al.
Pageof 13